drugset / Trial / NCT06855264
A Cardiac Liability Study of Varegacestat in Healthy Participants
RandomizedCrossoverDouble-blindOther
Summary
This clinical study is designed to study the effect of a single dose of varegacestat on cardiac repolarization in healthy adult participants.
Timeline
- Start
- 2025-02-24
- Primary completion
- 2025-04-08
- Completion
- 2025-05-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
| Subject | varegacestat | Small molecule | — | Oral |
Indications
No indication recorded.